Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-26

Clinical Trial Update: Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial NCT05610826 comparing preoperative PRRT to surgical cytoreduction for metastatic pancreatic neuroendocrine tumors to the liver has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Chicago | Conditions: Pancreatic Neuroendocrine Tumor, Pancreas Cancer | Phase 1, Phase 2 | Status: WITHDRAWN